No Data
No Data
Cabaletta Bio Is Maintained at Overweight by Wells Fargo
Cabaletta Bio Price Target Cut to $20.00/Share From $35.00 by Wells Fargo
Evercore ISI Group Maintains Outperform on Cabaletta Bio, Lowers Price Target to $15
Cabaletta Bio: Overweight Rating Maintained Amidst ICANS Incident and Adjusted Price Target
Express News | Cabaletta Bio Inc - Evercore ISI Cuts Target Price to $15 From $25
Cabaletta Bio Is Maintained at Buy by HC Wainwright & Co.
No Data
diamonds : Excuse me, can shares held still be valid after ENDPQ's restructuring?